Prostate Cancer, An Issue of Hematology/Oncology Clinics of North America, E-Book
Elsevier Health Sciences, 14 lis 2013 - 225
This issue of Hematology/Oncology Clinics is focused on Prostate Cancer and highlights topics such as: Prevention, Early Detection, Biomarkers, Risk stratification, Imaging in Prostate Cancer, Adjuvant hormonal therapy, Management of patient with biochemical relapse, Management of patient with newly metastatic disease, and Bone Health Management.
Co mówią ludzie - Napisz recenzję
Nie znaleziono żadnych recenzji w standardowych lokalizacjach.
Surgical Management of Prostate Cancer
Contemporary Issues in Radiotherapy for Clinically Localized Prostate Cancer
Imaging in Prostate Carcinoma
Neoadjuvant and Adjuvant Hormonal and Chemotherapy for Prostate Cancer
Management of Patients with Biochemical Recurrence After Local Therapy for Prostate Cancer
Management of HormoneSensitive Metastatic Prostate Cancer
Management of Patients with CastrationResistant Disease
Optimizing Bone Health and Minimizing Skeletal Morbidity in Men with Prostate Cancer
abiraterone active surveillance adjuvant advanced prostate cancer androgen deprivation therapy androgen receptor antiandrogens benefit bicalutamide biochemical recurrence biopsy bisphosphonates BJU Int bone metastases brachytherapy Cancer Res carcinoma castration castration-resistant prostate cancer cells chemotherapy Clin Oncol clinical trials clinically localized prostate ClinicalTrials.gov cohort compared CRPC Denosumab detection docetaxel dose EBRT enzalutamide evaluation follow-up fracture Gleason score high-risk prostate cancer hormonal therapy HSPC imaging improved increased inhibitor Int J Radiat localized prostate cancer long-term lymph node median metastatic metastatic disease metastatic prostate cancer months neoadjuvant ng/mL Nucl Oncol Biol Phys osteoblasts outcomes overall survival patients with prostate PCA3 PCSM pelvic PET/CT placebo predict prednisone primary end point prostate-specific antigen PSA level PSA screening PSADT Radiat Oncol Biol radiation therapy radical prostatectomy radiotherapy randomized trial reported risk RTOG salvage serum sipuleucel-T target toxicity treatment tumor Urol Urology versus zoledronic acid